March 18th 2024
Abecma (idecabtagene vicleucel) demonstrated a favorable benefit/risk profile for patients based on results from the pivotal Phase III KarMMa-3 study.
Phase III THARROS Trial to Evaluate Impact of Breztri Aerosphere on Cardiopulmonary Outcomes in COPD
THARROS trial investigators seek to provide first-of-its-kind evidence supporting a strategy of comprehensive cardiopulmonary risk reduction with a triple therapy in patients with chronic obstructive pulmonary disease.
New Technologies Enhancing Transparency Between Patients and Researchers
March 13th 2024In this Applied Clinical Trials video interview, Julia Lakeland, Chief Product Officer, uMotif, discusses the development of new technologies helping to foster trust and informed decision-making throughout the clinical trial process.
Reducing the Emotional and Logistical Burdens of Patient Participation
March 12th 2024In this Applied Clinical Trials video interview, Julia Lakeland, Chief Product Officer, uMotif, discusses what kinds of technologies can be developed to improve patient engagement while still maintaining data integrity.